Cite
Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
MLA
Lin, Xinqing, et al. “Serum Neurofilament Light Chain or Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Brain Metastases.” Journal of Neurology, vol. 269, no. 2, Feb. 2022, pp. 815–23. EBSCOhost, https://doi.org/10.1007/s00415-021-10660-0.
APA
Lin, X., Lu, T., Deng, H., Liu, C., Yang, Y., Chen, T., Qin, Y., Xie, X., Xie, Z., Liu, M., Ouyang, M., Li, S., Song, Y., Zhong, N., Qiu, W., & Zhou, C. (2022). Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases. Journal of Neurology, 269(2), 815–823. https://doi.org/10.1007/s00415-021-10660-0
Chicago
Lin, Xinqing, Tingting Lu, Haiyi Deng, Chunxin Liu, Yilin Yang, Tao Chen, Yinyin Qin, et al. 2022. “Serum Neurofilament Light Chain or Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Brain Metastases.” Journal of Neurology 269 (2): 815–23. doi:10.1007/s00415-021-10660-0.